Add to ORKGAbstract. Sulfadoxine-pyrimethamine (SP) is the first line antimalarial treatment in the Democratic Republic of Congo. Using polymerase chain reaction, we assessed the prevalence of mutations in the dihydrofolate reductase (dhfr
In vitro pyrimethamine response of Plastnodium fulciparum isolates and dihydrofolate reductase (dhfr...
Abstract. Sulfadoxine-pyrimethamine is one of the alternative antimalarial drugs used to treat chlor...
Background: Drug resistance contributes to the global malaria burden. Plasmodium falciparum dihydrof...
Abstract. The efficacy of sulfadoxine/pyrimethamine (S/P) in treatment of uncomplicated falciparum m...
Background - Sulphadoxine-pyrimethamine (SP) has been and is currently used for treatment of uncompl...
In eastern and southern Africa, there has been a rapid increase in the prevalence of alleles with mu...
International audienceMolecular investigations performed following the emergence of sulfadoxine-pyri...
Abstract. Plasmodium falciparum resistance to sulfadoxine/pyrimethamine (S/P) is due to mutations in...
Abstract Background In Tanzania, drug-resistant malaria parasites are an increasing public health co...
The selection of point mutation at codon 164 (from isoleucine to leucine) of the dihydrofolate reduc...
Background: Sulphadoxine-pyrimethamine (SP) has been and is currently used for treatment of uncompli...
Malaria is a major public health problem in the Democratic Republic of Congo. Despite progress achie...
In eastern and southern Africa, there has been a rapid increase in the prevalence of alleles with mu...
AbstractResistance to sulfadoxine–pyrimethamine (SP) in Plasmodium falciparum malaria parasites is a...
Over a 2-year study period, three methods [a test of therapeutic efficacy, an in-vitro assay, and se...
In vitro pyrimethamine response of Plastnodium fulciparum isolates and dihydrofolate reductase (dhfr...
Abstract. Sulfadoxine-pyrimethamine is one of the alternative antimalarial drugs used to treat chlor...
Background: Drug resistance contributes to the global malaria burden. Plasmodium falciparum dihydrof...
Abstract. The efficacy of sulfadoxine/pyrimethamine (S/P) in treatment of uncomplicated falciparum m...
Background - Sulphadoxine-pyrimethamine (SP) has been and is currently used for treatment of uncompl...
In eastern and southern Africa, there has been a rapid increase in the prevalence of alleles with mu...
International audienceMolecular investigations performed following the emergence of sulfadoxine-pyri...
Abstract. Plasmodium falciparum resistance to sulfadoxine/pyrimethamine (S/P) is due to mutations in...
Abstract Background In Tanzania, drug-resistant malaria parasites are an increasing public health co...
The selection of point mutation at codon 164 (from isoleucine to leucine) of the dihydrofolate reduc...
Background: Sulphadoxine-pyrimethamine (SP) has been and is currently used for treatment of uncompli...
Malaria is a major public health problem in the Democratic Republic of Congo. Despite progress achie...
In eastern and southern Africa, there has been a rapid increase in the prevalence of alleles with mu...
AbstractResistance to sulfadoxine–pyrimethamine (SP) in Plasmodium falciparum malaria parasites is a...
Over a 2-year study period, three methods [a test of therapeutic efficacy, an in-vitro assay, and se...
In vitro pyrimethamine response of Plastnodium fulciparum isolates and dihydrofolate reductase (dhfr...
Abstract. Sulfadoxine-pyrimethamine is one of the alternative antimalarial drugs used to treat chlor...
Background: Drug resistance contributes to the global malaria burden. Plasmodium falciparum dihydrof...